The “Beijing Protocol” for Leukemia
The haploidentical “Beijing Protocol” makes a donor available to nearly every leukemia patient.
The haploidentical “Beijing Protocol” makes a donor available to nearly every leukemia patient.
Personalized mRNA neoantigen vaccines help prevent recurrence after pancreatic cancer surgery.
The world’s first approved solid-tumor CAR-T is available in China, offering new hope for advanced gastric cancer.
Lab-grown heart muscle cells help restore heart function in severe heart failure patients.
Chinese brain-computer interface technology enables spinal-cord paralysis patients to stand and walk again.
The world’s first bispecific ADC delivers better outcomes for recurrent nasopharyngeal cancer.